Abstract Background Although large-scale. next-generation sequencing (NGS) studies of cancers hold promise for enabling precision oncology. challenges remain in integrating NGS with clinically validated biomarkers. Methods To overcome such challenges. https://www.sylvaingoudreau.com/product-category/papar/